Marinus to sell rare-disease voucher to Novo Nordisk for $110 million
[ad_1] Shares of Marinus Pharmaceuticals Inc. MRNS, -5.23% gained 7.9% in premarket trading on Thursday after the company said it plans to sell its Rare Pediatric Disease Priority Review Voucher…